PTPRC and Cholecystitis: Our findings from MR analysis suggest a causal relationship between CD45 on CD33br HLA-DR+ immune cells and cholecystitis in the European population, providing a novel perspective on the pathogenesis of the disease and identifying potential metabolic targets for treatment.